Subscribe to the newsletter
-
Save 20% on LentiFlash Luciferase ready to use viral vectors
16-02-2021This month only, customers can save 20% on ready to use LentiFlash Luciferase during a purchase made directly from Flash Therapeutics. -
Looking for an efficient CRISPR delivery system ?
15-02-2021LentiFlash™ particles carrying CRISPR-Cas9 technology show promising results to disrupt targeted genes in several therapeutic fields! -
GMP lentiviral particle manufacturing facilities to produce gene & cell therapy drugs
17-10-2018While supplying high quality vectors for research and preclinical purpose, the Vectalys’ platform is now accelerating its development by providing cGMP compliant large-scale lentiviral vectors for clinical applications on two sites in Paris and Toulouse (France) for different phases in GMP process.